Trial intelligence / Profile preview

SiRE: Silodosin in Real-life Evaluation

NCT01757769Phase 4Completed

Sponsor
Recordati SpA
Start
May 2011
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by Recordati SpA. Started May 2011; status: completed.

02

Drugs

silodosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT01757769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01757769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call